首页> 外文OA文献 >Cutting Edge: Delay and Reversal of T Cell Tolerance by Intratumoral Injection of Antigen-Loaded Dendritic Cells in an Autochthonous Tumor Model
【2h】

Cutting Edge: Delay and Reversal of T Cell Tolerance by Intratumoral Injection of Antigen-Loaded Dendritic Cells in an Autochthonous Tumor Model

机译:前沿:在原地肿瘤模型中通过肿瘤内注射抗原负载的树突状细胞延迟和逆转T细胞耐受性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The tumor environment exerts a powerful suppressive influence on infiltrating tumor-reactive T cells. It induces tolerance of adoptively transferred effector T cells as they enter tumors and maintains the tolerance of persisting tumor-infiltrating T cells. In an autochthonous prostate cancer model, in which tumor-reactive CD8 T cells are trackable, we demonstrate that both depletion of endogenous dendritic cells (DCs) and intratumoral injection of Ag-loaded mature DCs delayed the tolerization of tumor-infiltrating effector CD8 T cells. Intratumoral injection of Ag-loaded DCs also reactivated tolerized CD8 T cells in the tumor tissue. The observed effects lasted as long as the injected DCs persisted. These findings are consistent with a critical role of DCs in modulating T cell reactivity in the tumor environment. They also suggest new potential strategies to extend the functionality of transferred effector T cells and to restore function to tolerized tumor-infiltrating T cells for cancer immunotherapy.
机译:肿瘤环境对浸润的肿瘤反应性T细胞产生强大的抑制作用。当它们进入肿瘤时,它诱导过继转移的效应T细胞的耐受性,并维持持久的肿瘤浸润T细胞的耐受性。在可追踪肿瘤反应性CD8 T细胞的自体前列腺癌模型中,我们证明内源性树突状细胞(DC)的耗竭和载有Ag的成熟DC的瘤内注射均延迟了肿瘤浸润效应CD8 T细胞的耐受性。肿瘤内注射载有Ag的DC也重新激活了肿瘤组织中耐受的CD8 T细胞。只要注入的DC持续存在,观察到的效果就会持续。这些发现与DC在调节肿瘤环境中T细胞反应性中的关键作用一致。他们还提出了新的潜在策略,以扩展转移的效应T细胞的功能并恢复耐受的肿瘤浸润T细胞的功能,以用于癌症免疫治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号